Publicaciones en colaboración con investigadores/as de Karolinska Institute (10)

2024

  1. Red blood cells as potential materials for microRNA biomarker study: overcoming heparin-related challenges

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 327, Núm. 5, pp. H1296-H1302

  2. miR-210 as a therapeutic target in diabetes-associated endothelial dysfunction

    British Journal of Pharmacology

2023

  1. Extracellular vesicles and their non-coding RNA cargos: Emerging players in cardiovascular disease

    Journal of Physiology, Vol. 601, Núm. 22, pp. 4989-5009

  2. Hypoxic erythrocytes mediate cardioprotection through activation of soluble guanylate cyclase and release of cyclic GMP

    Journal of Clinical Investigation, Vol. 133, Núm. 17

  3. Stimulation of Erythrocyte Soluble Guanylyl Cyclase Induces cGMP Export and Cardioprotection in Type 2 Diabetes

    JACC: Basic to Translational Science, Vol. 8, Núm. 8, pp. 907-918

  4. The red blood cell as a mediator of endothelial dysfunction in patients with familial hypercholesterolemia and dyslipidemia

    Journal of Internal Medicine, Vol. 293, Núm. 2, pp. 228-245

2022

  1. Downregulation of Erythrocyte miR-210 Induces Endothelial Dysfunction in Type 2 Diabetes

    Diabetes, Vol. 71, Núm. 2, pp. 285-297

  2. Erythrocytes Induce Vascular Dysfunction in COVID-19

    JACC: Basic to Translational Science, Vol. 7, Núm. 3, pp. 193-204

  3. Erythrocytes from patients with ST-elevation myocardial infarction induce cardioprotection through the purinergic P2Y13 receptor and nitric oxide signaling

    Basic Research in Cardiology, Vol. 117, Núm. 1

2021

  1. MicroRNA: A mediator of diet-induced cardiovascular protection

    Current Opinion in Pharmacology, Vol. 60, pp. 183-192